The Patent Finder

Beta Pharma Canada Inc.

Also on record
Records under this name other than patents Beta Pharma Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Beta Pharma Canada Inc.

PatentTitleStatus Expires Confidence
US 8,404,736Heterocyclic amide derivatives as EP4 receptor antagonists
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,458,162Cyclic molecules as bruton's tyrosine kinase inhibitors
Formerly held
Lapsed on the fee record
Ended Oct 4, 2024 · From the USPTO record
Lapsed on the fee recordEnded Oct 4, 2024From the USPTO record
US 9,226,923Spirocyclic molecules as protein kinase inhibitors
Formerly held
Lapsed on the fee record
Ended Jan 5, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 5, 2024From the USPTO record
US 9,345,905Heterocyclic amides compounds which are HDAC6 inhibitors and used as anti-tumoral agents
Formerly held
Lapsed on the fee record
Ended May 24, 2020 · From the USPTO record
Lapsed on the fee recordEnded May 24, 2020From the USPTO record
US 8,946,445Heterocyclic molecules as apoptosis inducers
Formerly held
Lapsed on the fee record
Ended Feb 3, 2019 · From the USPTO record
Lapsed on the fee recordEnded Feb 3, 2019From the USPTO record
US 8,937,088Ureas for the treatment and prevention of cancer
Lapsed on the fee record
Ended Jan 20, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jan 20, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited